Conference
Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin’s or Hodgkin’s lymphoma
Abstract
PURPOSE: In patients in whom bone marrow transplantation (BMT) fails, recurrence often occurs at sites known to have contained disease before initiating BMT. The purpose of this study was to find the maximal tolerable dose of locoregional irradiation (LRT) between 1000 and 2000 cGy that could be integrated with our Cytoxan-total body irradiation (TBI) BMT conditioning regimen in the treatment of lymphoma.
METHODS AND MATERIALS: Patients had …
Authors
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D
Volume
57
Pagination
pp. 166-171
Publisher
Elsevier
Publication Date
9 2003
DOI
10.1016/s0360-3016(03)00508-x
Conference proceedings
International Journal of Radiation Oncology • Biology • Physics
Issue
1
ISSN
0360-3016